AAOMS Annual Meeting

The FDA has warned that the antipsychotic drug, olanzapine, may be associated with a rare but serious skin reaction.

The FDA finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco, and pipe tobacco, among others.

The FDA finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco, and pipe tobacco, among others.

The FDA finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco, and pipe tobacco, among others.

The FDA told manufacturers of a drug/device combination to treat schizophrenia they must provide more information before the product can be considered for approval.

The FDA told manufacturers of a drug/device combination to treat schizophrenia they must provide more information before the product can be considered for approval.

The FDA told manufacturers of a drug/device combination to treat schizophrenia they must provide more information before the product can be considered for approval.

In response to evidence from several large trials, the FDA has decided to withdraw its approval of niacin and fibrate in combination with statins.

In response to evidence from several large trials, the FDA has decided to withdraw its approval of niacin and fibrate in combination with statins.

In response to evidence from several large trials, the FDA has decided to withdraw its approval of niacin and fibrate in combination with statins.